Plus Therapeutics Appoints Michael Rosol, Ph.D., as Chief Development Officer
Position
Chief Development Officer
Company
Cerenome, Inc.
HoustonManufacturingBiotechnologyHealth CareTherapeuticsPharmaceuticalHealth DiagnosticsDescription
Plus Therapeutics announced the appointment of Dr Michael Rosol as Chief Development Officer. Dr Rosol will lead the company’s clinical, pre-clinical, and biomarker development activities, bringing his extensive experience in oncology and radiotherapeutic drug development to the role.
Quick answer
Plus Therapeutics Appoints Michael Rosol, Ph.D., as Chief Development Officer (February 24, 2025). Cerenome, Inc. is based in Houston, Texas, United States.
- Who is the new Chief Development Officer at Cerenome, Inc?
- Cerenome, Inc. named Michael Rosol Chief Development Officer, announced February 24, 2025.
- What did Cerenome, Inc. announce on February 24, 2025?
- Plus Therapeutics announced the appointment of Dr Michael Rosol as Chief Development Officer. Dr Rosol will lead the company’s clinical, pre-clinical, and biomarker development activities, bringing his extensive experience in oncology and radiotherapeutic drug development to the role.
- What does Cerenome, Inc. do?
- Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company developing targeted radiotherapeutics for difficult-to-treat cancers of the central nervous system with the potential to enhance clinical outcomes for...
- Where is Cerenome, Inc. based?
- Cerenome, Inc. is based in Houston, Texas, United States.
- Which similar companies made leadership changes around the same time?
- Bristol Myers Squibb (February 21, 2025), Pfizer (February 24, 2025), Crinetics Pharmaceuticals (February 26, 2025) and Iovance Biotherapeutics (February 16, 2025) also announced leadership changes within 45 days of Cerenome, Inc.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Bristol-Myers Squibb Appoints Cari Gallman as Executive Vice President and General Counsel, Succeeding Sandra Leung (February 21, 2025)
- Pfizer Hires Dr. Patrizia Cavazzoni as Chief Medical Officer to Replace Dr. Aida Habtezion (February 24, 2025)
- Crinetics Pharmaceuticals Appoints Tobin “Toby” Schilke as Chief Financial Officer (February 26, 2025)
- Iovance Biotherapeutics Appoints Dan Kirby as Chief Commercial Officer (February 16, 2025)
- Revelation Pharma Promotes Nancy Fingerhut to Vice President of Quality Assurance and Regulatory Affairs (February 12, 2025)
- Santhera Pharmaceuticals Appoints Catherine Isted as CFO, Andrew Smith to Step Down (February 10, 2025)
Who to call at Cerenome, Inc., and when
A new leader at Cerenome, Inc. brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Cerenome, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cerenome, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cerenome, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cerenome, Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Cerenome, Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.